Consensus Takeda Pharmaceutical Company Limited Wiener Boerse

Equities

TKD

JP3463000004

End-of-day quote Wiener Boerse Other stock markets 06:00:00 2024-06-13 pm EDT			5-day change	1st Jan Change
24.49 ^EUR	+0.16%		-1.45%	-5.15%

Jun. 14	Takeda Signs Option Agreement with Ascentage to License Leukemia Drug	MT
Jun. 14	Takeda Pharmaceutical Company Limited Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, Third-Generation BCR-ABL Tyrosine Kinase Inhibitor	CI

Evolution of the average Target Price on Takeda Pharmaceutical Company Limited

Price target over the last 5 years

History of analyst recommendation changes

f84cdf32ed1f817937f7d85.NhS_g2S8WZ0VFN29-hot4UHrrihLfEDSEKH5DfB4pUg.UlLW5Sv5YekkX4qOk1dgpRO4gxoDUQe0UsiJdYoS8SZaYOn1L8Yvx3Qgvg~2d013741002b6a0690362bf4c450d24a

Analyst Recommendations on Takeda Pharmaceutical Company Limited

Toyota becomes Asia's most shorted large-cap stock - Hazeltree	Mar. 12	RE
Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy	Feb. 13	MT
Brazil's consumer prices forecast to have risen faster in Sept - Reuters poll	23-10-10	RE
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy	23-10-03	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy	23-09-22	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy	23-05-31	MT
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating	23-05-16	MT
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating	23-04-04	MT
BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20	23-03-16	MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy	23-03-06	MT
Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy	22-08-01	MT
Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform	22-07-19	MT
TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight	21-10-07	MT
Japan Petroleum Exploration : Japanese shares end higher on Wall Street gains, stable U.S. rates	21-05-21	RE
Japanese shares fall on profit booking, checking U.S. rates	21-04-05	RE
Takeda Pharmaceutical : Says Phase 3 Study Results Show Takhzyro Curbed HAE Attack Rate Long Term	20-11-13	MT
Takeda Pharmaceutical Company Limited: Takeda Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year	19-07-31	EQ
Takeda Pharmaceutical : Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year	19-07-31	BU
Takeda Pharmaceutical : Announces Execution of Loan Agreement in Connection with Proposed Acquisition of Shire plc	18-12-03	BU
Takeda Pharmaceutical : Announces Execution of Senior Short Term Loan Facility Agreement and Subordinated Syndicated Loan Agreement and Second Amendment to Bridge Credit Agreement in Connection with Proposed Acquisition of Shire plc	18-10-26	BU
BAYER : Germany's Merck hires JP Morgan to sell consumer health	17-09-08	RE